Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6312
|
pubmed:dateCreated |
1982-5-21
|
pubmed:abstractText |
Regular or crystalline insulin with sodium glycocholate as surfactant administered intranasally to normal volunteers induced hypoglycaemia and an increase in serum immunoreactive insulin concentrations. Serum C-peptide concentrations decreased or remained unchanged. Insulin administered intravenously to three of these subjects yielded a potency ratio of 1:8 for intranasal and intravenous insulin. In four insulin-dependent diabetics a cross-over study was performed on different days, insulin being administered once intranasally and once subcutaneously in a ratio of 1:9. In these patients the intranasal insulin was more effective than the subcutaneous insulin in preventing hyperglycaemia after breakfast. In four other insulin-dependent diabetics 11-hours monitoring was performed twice on two different days, insulin being administered in divided dosage sufficient to achieve a reasonable glycaemic profile. The administration during the morning, whereas subcutaneous insulin was more effective than intranasal during the afternoon.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-1239396,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-13952078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-25215,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-4613793,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-5673348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-5681079,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-6105520,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6800439-679460
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0267-0623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
303-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6800439-Administration, Intranasal,
pubmed-meshheading:6800439-Blood Glucose,
pubmed-meshheading:6800439-Diabetes Mellitus,
pubmed-meshheading:6800439-Humans,
pubmed-meshheading:6800439-Hypoglycemia,
pubmed-meshheading:6800439-Injections, Subcutaneous,
pubmed-meshheading:6800439-Insulin,
pubmed-meshheading:6800439-Time Factors
|
pubmed:year |
1982
|
pubmed:articleTitle |
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|